Trelegy Ellipta
Trelegy Ellipta is an originator product from GlaxoSmithKline AG and is listed on the FOPH Specialities List. Swiss mandatory health insurance therefore reimburses it within the authorised indication. The public price ranges from CHF 76.80 to CHF 197.55 depending on the pack; the patient co-payment is 10 per cent plus the deductible.
Core data
- Authorisation holder
- GlaxoSmithKline AG
- ATC code
- R03AL08
- IT group
- 03.99 Varia
- Active substances
- Fluticasoni furoas, Umeclidinium, Vilanterolum
- Preparation type
- Originator product
- On the SL since
- 01/01/2019
- Last price change
- 01/12/2025
- Co-payment
- 10%
Prices per pack
The ex-factory price is the authorisation holder's price; the public price adds the distribution share and VAT. Both are FOPH maximum prices: nothing above them may be charged.
| Dosage form | Pack size | Ex-factory price | Public price | Valid from | Cat. | GTIN |
|---|---|---|---|---|---|---|
| Inh Plv 92/55/22mcg | 30 Dos | CHF 55.52 | CHF 76.80 | 01/01/2019 | B | 7680668080014 |
| Inh Plv 92/55/22mcg | 3 x 30 Dosen | CHF 166.55 | CHF 197.55 | 01/01/2019 | B | 7680668080021 |
Limitation
This preparation is reimbursed only under the conditions below. The text is the binding FOPH wording; outside those conditions basic insurance does not pay.
The FOPH publishes limitation texts in German, French and Italian only. The German wording is reproduced verbatim below.
oder
für Patienten mit moderater bis schwerer COPD nach ≥ 2 moderaten Exazerbationen oder 1 Exazerbation, welche zu einer Hospitalisation geführt hat trotz einer mindestens 3 Monaten dauernden optimierter Therapie unter ICS/LABA oder LABA/LAMA (für LABA/LAMA mit Eosinophilenzellzahl im Blut ≥ 100 Zellen/µl), welche nicht ausreichend eingestellt sind
oder
für Patienten mit COPD, welche bereits mit einer Kombination von LABA/LAMA und ICS oder ICS/LABA und LAMA mit mehreren Inhalatoren therapiert werden.
FAQ
Is Trelegy Ellipta covered by Swiss health insurance?
Yes, but only under conditions. Trelegy Ellipta is on the Specialities List with a limitation: basic insurance reimburses it only when the conditions in the limitation text are met, in some cases only after the insurer has granted cost approval.
What does Trelegy Ellipta cost in Switzerland?
The public price is the maximum price set by the FOPH and for Trelegy Ellipta ranges from CHF 76.80 to CHF 197.55 per pack. The ex-factory price ranges from CHF 55.52 to CHF 166.55. Pharmacies may not charge more, but may charge less.
Market access
Do you need your product on the Specialities List?
Questions about SL listing, prices or limitations? Contact Swiss Reimbursement.
- Independent directory
- Official FOPH data
- Website in eight languages